I70.512
Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, left leg
Clinical Classification Guidelines
Medical Intelligence & Overview
Atherosclerosis of nonautologous biological bypass grafts in the extremities, particularly affecting the left leg, is a condition where fatty deposits build up in the blood vessels supplying the leg. This narrowing can lead to reduced blood flow, causing symptoms such as intermittent claudication, which is muscle pain or cramping that occurs during activity and eases with rest. This condition is a common complication for individuals who have had vascular bypass surgeries using biological grafts, and it requires proper management to prevent more severe circulatory problems.
Causes & Symptoms
Clinical Causes: Progressive buildup of fatty deposits (atherosclerosis) within the graft vessel Presence of risk factors such as high cholesterol levels, high blood pressure, smoking, and diabetes Age-related changes in blood vessels that contribute to narrowing over time Inflammation or injury to the blood vessel lining, leading to plaque formation Poor blood flow or turbulence within the graft, promoting plaque accumulation
Key Symptoms: Intermittent claudication — muscle pain or cramping in the leg during activity, which subsides with rest Weakness or fatigue in the affected leg Numbness or tingling sensation in the leg Coldness or pallor in the skin of the affected limb In severe cases, rest pain or skin ulcers may develop, indicating critical limb ischemia
Diagnostic & Treatment
Diagnosis Path: Doppler ultrasound — to evaluate blood flow within the graft and the native vessels Ankle-brachial index (ABI) measurement — compares blood pressure in the ankle and arm to assess arterial narrowing Angiography — an imaging procedure to visualize blood flow and pinpoint blockages or narrowing in the graft Magnetic Resonance Angiography (MRA) or Computed Tomography Angiography (CTA) — detailed imaging techniques for assessing graft health
Treatment Protocols: Lifestyle modifications: quitting smoking, maintaining a healthy diet, and engaging in supervised exercise programs Medications: antiplatelet agents to reduce blood clot risk, cholesterol-lowering drugs, and medications to control blood pressure and blood sugar levels Minimally invasive procedures: balloon angioplasty or stenting to open narrowed sections of the graft Surgical revision or bypass procedures: in cases where the graft is severely blocked or has failed Regular monitoring: ongoing assessments to detect early signs of graft deterioration or recurrent narrowing
Clinical Advice & FAQs
Billing Guidance
Is I70.512 a billable ICD-10 code?
Yes, I70.512 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report I70.512?
Clinical documentation must specify the nature of Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, left leg and any associated comorbidities for accurate reporting.
Cite this Clinical Reference